MARKET

PGEN

PGEN

Precigen Inc
NASDAQ
4.540
-0.120
-2.58%
After Hours: 4.520 -0.02 -0.44% 19:41 11/13 EST
OPEN
4.660
PREV CLOSE
4.660
HIGH
4.710
LOW
4.510
VOLUME
3.78M
TURNOVER
--
52 WEEK HIGH
8.98
52 WEEK LOW
3.040
MARKET CAP
1.63B
P/E (TTM)
101.57
1D
5D
1M
3M
1Y
5Y
1D
Inovio price target lowered to $6 from $8 at Piper Sandler
TipRanks · 3d ago
Shareholders In Precigen (NASDAQ:PGEN) Should Look Beyond Earnings For The Full Story
Simply Wall St · 3d ago
Precigen (PGEN) Earnings Turnaround Puts Its Valuation Back In Focus
Simply Wall St · 5d ago
Precigen Posts Strong Q3: PAPZIMEOS Net Revenue Rose 37%; Positive Cash Flow Achieved Ahead of Schedule
Barchart · 5d ago
What Makes Precigen (PGEN) a New Buy Stock
NASDAQ · 5d ago
PGEN Q3 Earnings Call Highlights Launch Momentum and Competition
NASDAQ · 5d ago
Weekly Report: what happened at PGEN last week (1102-1106)?
Weekly Report · 5d ago
Precigen Stock Turns Heads After Q3 Profit Swing
Simply Wall St · 6d ago
More
About PGEN
Precigen, Inc. is a discovery and clinical-stage biopharmaceutical company developing gene and cell therapies for improving outcomes for patients with unmet medical needs. The Company’s proprietary technology platforms develop product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. It has developed a pipeline of therapies across multiple indications. The Company’s segments include Biopharmaceuticals and Exemplar. The Biopharmaceuticals segment is primarily comprised of the Company's legal entities as well as royalty interests in therapeutics and therapeutic platforms from companies not controlled by the Company. The Exemplar is composed of Exemplar Genetics LLC, doing business as Precigen Exemplar, its wholly owned subsidiary focused on developing research models and services for healthcare research applications.

Webull offers Precigen Inc stock information, including NASDAQ: PGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PGEN stock methods without spending real money on the virtual paper trading platform.